Acta Scientific Paediatrics (ISSN: 2581-883X)

Case Series Volume 5 Issue 8

BCG Adverse Effects in Infants - Case Series

Chakradhar Maddela*

Neonatologist, Department of Neonatology, ESIC Medical College, Sanath Nagar, Hyderabad, India

*Corresponding Author: Chakradhar Maddela, Neonatologist, Department of Neonatology, ESIC Medical College, Sanath Nagar, Hyderabad, India.

Received: June 28, 2022; Published: July 27, 2022


Bacillus Calmette-Guerin (BCG) is widely using vaccination for prevention of tuberculosis in children globally. BCG adverse effects are uncommon. Common adverse effects include BCG abscess, non-suppurative and suppurative lymphadenitis and rarely BCG disseminated disease. Common therapeutic strategies for BCG complications include wait and watch policy, needle aspiration, antibiotic therapy and surgery. Correct guidelines when and how to manage BCG complications are not available. We came across four cases of BCG adverse effects recently. All four cases were noted, followed up and presenting as case series with literature review on how to treat.

Keywords: BCG; Vaccination; Complications; Management


  1. Rodrigues LC., et al. “Protective effect of BCG against tuberculosis meningitis and miliary tuberculosis: a meta-analysis”. International Journal of Epidemiology 22 (1993): 1154-1158.
  2. Venkatraman A., et al. “Management and outcome of Bacille Calmette - Guerin vaccine adverse reactions”. Vaccine 33 (2016): 5470-5474.
  3. Al-Mousa Hamond., et al. “An infant with disseminated baccillus Calmette - Buerin infection (BCGitis)”. International Journal of Pediatrics and Adolescent Medicine 1 (2014): 89-92.
  4. Alfawaz TS., et al. “BCG related complications: A single centre prospective observational study”. International Journal of Pediatrics and Adolescent Medicine 2 (2015): 75-78.
  5. Vikkanueva P., et al. “What is the significance of an accelerated BCG reaction in children?” Archives of Disease in Childhood 5 (2022).
  6. Nissen TN., et al. “Adverse reactions to the Bacillus Calmette-Guerin (BCG) vaccine in new-born infants - an evaluation of the Danish strain 1331 SSI in a randomized clinical trial”. Vaccine 34 (2016): 2477-2482.
  7. Mostaan S., et al. “Adverse effects of BCG vaccine 1173 P2 in Iran: A meta-analysis”. Advanced Biomedical Research 5 (2016): 99.
  8. Goraya JS and Virdi VS. “Bacille Calmette-Guerin lymphadenitis”. Postgraduate Medical Journal 920 (2002): 327-329.
  9. Aoki Y., et al. “Unusual wound healing following suppurative BCG lymphadenitis”. BMJ Case Reports (2018).
  10. Banani SA and Alborzi A. “Needle aspiration for suppuration post-BCG adenitis”. Archives of Disease in Childhood 71 (1994): 446-447.


Citation: Chakradhar Maddela. “BCG Adverse Effects in Infants - Case Series". Acta Scientific Paediatrics 5.8 (2022): 26-30.


Copyright: © 2022 Chakradhar Maddela. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate33%
Acceptance to publication20-30 days
Impact Factor1.197

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US